Huggies

Quick Take

Kimberly-Clark's federal political footprint is small for a company its size and it says so openly. It reported $990,000 in federal lobbying for calendar 2024 in its own published disclosure, a figure matching the OpenSecrets total exactly, and $1,580,000 for calendar 2025. Across the entire 2024 election cycle, OpenSecrets recorded just $55,018 in contributions associated with the company, with no corporate PAC behind any of it and no identified affiliates. The company's most visible public-issue work under the Huggies name is diaper need, a cause it has funded since 2011 and one that has drawn participation from elected officials of both parties. The largest political question hanging over the company right now is one it bought on purpose.

A Company That Says It Has No PAC

Kimberly-Clark maintains a Government Relations and Political Activity page under its sustainability framework, last published in June 2025. It states that the company advocates both directly and through trade and industry associations, and that it leverages industry association engagement to advance progress on sustainability-related policy. It then says plainly: "We do not have a Political Action Committee (PAC)," adding that employees may participate in politics personally, on their own time and at their own expense.[1]

The company's own annual disclosure goes further than the missing PAC. It states that Kimberly-Clark does not use corporate funds to contribute to any federal, state or local candidates, political parties or political committees, and that its Code of Conduct bars employees from making political contributions on the company's behalf. It frames its public-policy work as business driven and reflective of its corporate culture, overseen by the board's Nominating and Corporate Governance Committee. The company reserves the right to fund state or local ballot initiatives that directly affect its business, but reports spending $0 on them in 2024.[2]

The numbers are consistent with that. OpenSecrets recorded $55,018 in contributions associated with Kimberly-Clark for the 2024 election cycle, which under the OpenSecrets two-year binning runs from January 1, 2023 through December 2024. With no corporate PAC, every dollar of that is individual giving of $200 or more from employees, executives and their immediate family members, not a company decision. In 2024 it split about 65 percent to Democrats and 35 percent to Republicans, the largest single amounts going to Kamala Harris (about $22,900) and Donald Trump (about $11,300), with smaller sums to Wisconsin Senator Tammy Baldwin, the Republican National Committee, ActBlue and Nikki Haley. Because the giving is individual rather than PAC-directed, its partisan tilt swings hard between cycles: it ran about 52 percent Democratic in the 2020 presidential cycle and roughly even in 2016, but 85 percent Republican in the 2022 midterm and 86 percent Democratic in 2018, with no steady company hand on it. OpenSecrets identified no affiliates and recorded no outside spending in the cycle.[3]

For a company with $16.4 billion in annual sales, that is an unusually small number. Kimberly-Clark did once run a corporate PAC, but its last recorded PAC contributions to candidates and parties fall in the 1992 election cycle, and OpenSecrets has logged none in the decades since, matching the company statement that it operates no PAC today.[3]

Lobbying is a separate accounting, filed by calendar year under the Lobbying Disclosure Act. Kimberly-Clark reported $990,000 in 2024 and $1,580,000 in 2025.[4] The bills it lobbied on in 2024 map closely to its product lines: the bipartisan Tax Relief for American Families and Workers Act, the WIPPES Act on flushable-wipe labeling, a bill funding menstrual-product access through the Social Services Block Grant, the End Diaper Need Act, and a trade bill involving Ecuador.[4] The company publishes its own annual Government Relations and Political Activity Disclosure, and its 2024 edition states the same $990,000 figure, describing it as covering internal lobbying expenses, retained consultants' fees, and the portion of trade association dues attributable to lobbying, though it does not itemize which associations or how much.[2] The roughly 60 percent increase into 2025 tracks a year in which the company was pursuing the largest acquisition in its history.

Publishing a disclosure that matches the federal record, and saying outright that no PAC exists, is itself a governance posture. It is the company choosing transparency over reach.

Buying Tylenol at the Worst Possible Moment

On November 3, 2025, Kimberly-Clark announced it would acquire Kenvue, the Johnson and Johnson consumer health spinoff behind Tylenol, Band-Aid, Listerine, Neutrogena and Aveeno, in a cash and stock deal valued at about $48.7 billion. Kenvue shareholders were to receive $3.50 per share in cash plus 0.14625 Kimberly-Clark shares. Kimberly-Clark shareholders would own roughly 54 percent of the combined company, Kenvue shareholders about 46 percent, with roughly $32 billion in combined annual revenue and a forecast $2.1 billion in annual cost savings.[5][6][7]

The timing was the story. In September 2025, President Trump announced that the Food and Drug Administration would issue a physician notice and begin updating safety labels for acetaminophen, tying its use during pregnancy to autism. "Don't take Tylenol if you're pregnant," he said.[6] The FDA initiated a label change for acetaminophen in September 2025 and notified physicians of a possible link to neurological conditions including autism and ADHD.[7] The administration's own written clinical guidance was narrower, telling clinicians to exercise their best judgment, and the FDA noted that acetaminophen is the only over-the-counter drug approved to treat fever in pregnancy.[6]

Kenvue disputed the link, filed a petition with the FDA rebuking the claims, and continued to say the drug is safe.[7] United States Tylenol sales fell 11 percent between September 20 and October 4, 2025, according to an analyst estimate cited by Reuters, and Kenvue had already ousted its chief executive that July.[8] Kimberly-Clark shares dropped sharply on the announcement as investors questioned the 46 percent premium.[7]

Shareholders of both companies approved the deal on January 29, 2026, with roughly 96 percent of shares present at Kimberly-Clark's special meeting voting in favor and about 99 percent of votes cast at Kenvue's.[9] The Hart-Scott-Rodino waiting period expired February 4, 2026, and the transaction remained pending foreign regulatory approvals with closing expected in the second half of 2026.[10]

The legal exposure has not resolved. On July 13, 2026, the Second Circuit Court of Appeals revived more than 500 private lawsuits alleging prenatal acetaminophen use caused autism or ADHD, holding that a district judge had improperly excluded expert testimony from three doctors. The appeals court did not rule that Tylenol causes either condition, and the exclusion of two other experts was left standing. Kenvue responded that the decision does not change what it called "credible, independent science shows no proven link" between acetaminophen and autism or ADHD. Kimberly-Clark did not immediately comment.[11] In June 2026 the Society for Maternal-Fetal Medicine stated that the available evidence does not establish a causal relationship and continued to recommend acetaminophen as a first-line option in pregnancy.[12]

This is litigation and regulatory conduct rather than political positioning, and it belongs in the record as such. What is politically legible is the decision itself: Kimberly-Clark chose to move into the Tylenol business, not away from it, with the controversy still unfolding.

Diaper Need, and Who Shows Up for It

The most sustained public-issue work carried out under the Huggies name is not obviously partisan, which is part of what makes it worth reading closely.

Kimberly-Clark commissioned research in 2010 finding that one in three United States families struggled to afford clean diapers. In 2011 Huggies became the founding sponsor of the National Diaper Bank Network, and it has been the network's largest donor since.[13][14]

The political participation around it has come from both directions. In March 2016, Huggies announced a donation of 22 million diapers in direct response to a call from President Obama for companies to address diaper need.[14] In September 2019, during National Diaper Need Awareness Week, Kimberly-Clark volunteers repacked diapers in Neenah, Wisconsin alongside Republican State Senator Roger Roth and Republican Representatives Jim Steineke and Dave Murphy.[15]

On January 15, 2026, Huggies announced 15 million diapers delivered in 15 days for the network's fifteenth anniversary, the opening tranche of an expanded commitment totaling 75 million diapers over three years, reaching diaper banks in 33 states and the District of Columbia.[13]

Diaper need intersects with policy, including state sales tax exemptions on diapers and proposals to cover them under public benefit programs. The company's documented activity here is donation and awareness rather than legislative advocacy, and it is worth keeping those two things distinct.

How the Company Talks About Its Workforce

Kimberly-Clark frames its workforce policy under the heading Belonging and Inclusion, maintained as a standing page within its 2030 Ambition sustainability framework and linked from the company's main navigation.[16] The vocabulary is notable in itself: belonging and inclusion rather than the diversity, equity and inclusion formulation, a framing the company was using before the 2025 wave of corporate revisions.

What Huggies Is and What Kimberly-Clark Sells

Huggies is a diaper, training pant and baby wipe brand more than 40 years old, sold alongside Pull-Ups and Goodnites in Kimberly-Clark's baby and child care business. It is the national sponsor of Hand to Hold, a nonprofit supporting families through NICU stays and infant loss, and it has worked with NICU nurses to develop products for premature infants.[13]

Kimberly-Clark itself dates to 1872 and employs about 36,000 people as of the end of 2025.[19] Its brands, which it says hold the number one or number two share position in roughly 70 countries, include Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, sold in more than 175 countries and territories.[9] The company moved its stock listing from the New York Stock Exchange to Nasdaq during 2025 and is headquartered in Dallas.[17]

Recent News

Kimberly-Clark reported full year 2025 net sales of $16.4 billion, down 2.1 percent, with organic sales growth of 1.7 percent led by volume growth of 2.5 percent, and adjusted operating profit of about $2.7 billion, roughly level with 2024 as efficiency gains offset pricing pressure, cost inflation and tariffs. Fourth quarter net sales were $4.1 billion, down 0.6 percent, with the decline driven by the company's exit from its United States private label diaper business. Fourth quarter adjusted earnings per share rose 24 percent to $1.86. Total debt stood at $7.2 billion at year end, down from $7.4 billion.[17][18]

The company raised its quarterly dividend to $1.28 per share and is building an $800 million plant in Trumbull County, Ohio.[18] For 2026 it expects organic sales growth in line with or ahead of category growth, which it puts at roughly 2 percent.[17]

Where to Find Them

Huggies products are sold through grocery, mass, club, drug and online retailers across the United States, with product and program information at huggies.com. Kimberly-Clark Corporation is headquartered in Dallas, Texas, trades on Nasdaq under KMB, and files annual reports on Form 10-K with the Securities and Exchange Commission. Corporate information is at kimberly-clark.com.[9][17]

Footnotes

[1] Kimberly-Clark Corporation, "Government Relations and Political Activity," published June 2025. https://www.kimberly-clark.com/en-us/sustainability/2030-ambition/political-contributions

[2] Kimberly-Clark Corporation, "2024 Government Relations and Political Activity Disclosure," accessed August 13, 2026. https://www.kimberly-clark.com/-/media/kimberly/pdf/investors/KC-2024-Government-Relations-Disclosure.pdf

[3] OpenSecrets, "Kimberly-Clark Corp Profile: Summary and Totals," organization ID D000035098, accessed August 13, 2026. https://www.opensecrets.org/orgs/kimberly-clark-corp/summary?id=D000035098 and https://www.opensecrets.org/orgs/kimberly-clark-corp/totals?id=D000035098

[4] OpenSecrets, "Kimberly-Clark Corp Lobbying Profile," organization ID D000035098, accessed August 13, 2026. https://www.opensecrets.org/federal-lobbying/clients/summary?id=D000035098 and https://www.opensecrets.org/orgs/kimberly-clark-corp/lobbying?id=D000035098

[5] CBS News, "Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal," November 3, 2025. https://www.cbsnews.com/news/kenvue-kimberly-clark-acquisition-tylenol/

[6] Scripps News, "Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal," November 3, 2025. https://www.aol.com/finance/kimberly-clark-buying-tylenol-maker-124340974.html

[7] Al Jazeera, "Kimberly-Clark to buy Tylenol maker Kenvue for $40bn," November 3, 2025. https://www.aljazeera.com/economy/2025/11/3/kimberly-clark-to-buy-tylenol-maker-kenvue-for-40bn

[8] Reuters, "Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal," November 3, 2025. https://finance.yahoo.com/news/tylenol-maker-kenvue-misses-sales-132413546.html

[9] Kimberly-Clark Corporation and Kenvue Inc., Form 8-K Exhibit 99.1, "Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue," January 29, 2026. https://www.sec.gov/Archives/edgar/data/55785/000110465926008005/tm262467d8_ex99-1.htm

[10] Kenvue Inc., "Kenvue Reports Fourth Quarter and Full Year 2025 Results," February 2026. https://investors.kenvue.com/financial-news/news-details/2026/Kenvue-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx

[11] Reuters via Claims Journal, "US Appeals Court Revives Hundreds of Private Lawsuits Linking Tylenol to Autism," July 13, 2026. https://www.claimsjournal.com/news/national/2026/07/13/338786.htm

[12] Society for Maternal-Fetal Medicine, "SMFM Reaffirms Acetaminophen as First-Line Medication for Treating Pain and Fever During Pregnancy," June 1, 2026. https://www.smfm.org/news/smfm-reaffirms-acetaminophen-as-first-line-medication-for-treating-pain-and-fever-during-pregnancy

[13] Kimberly-Clark Corporation, "Huggies Donates 15 Million Diapers in 15 Days in Celebration of National Diaper Bank Network's 15th Anniversary," January 15, 2026. https://www.prnewswire.com/news-releases/huggies-donates-15-million-diapers-in-15-days-in-celebration-of-national-diaper-bank-networks-15th-anniversary-302661608.html

[14] Kimberly-Clark Corporation, "Huggies Brand Answers President Obama's Call to Help Fight Diaper Need," March 10, 2016. https://www.investor.kimberly-clark.com/news-releases/news-release-details/huggies-brand-answers-president-obamas-call-help-fight-diaper

[15] 3BL Media, "As Diaper Need Awareness Grows, Kimberly-Clark and Huggies Applaud Efforts of Elected Leaders," September 2019. https://www.3blmedia.com/news/diaper-need-awareness-grows-kimberly-clark-and-huggies-applaud-efforts-elected-leaders-champion

[16] Kimberly-Clark Corporation, "Belonging and Inclusion," 2030 Ambition. https://www.kimberly-clark.com/en-us/sustainability/2030-ambition/belonging-and-inclusion

[17] Kimberly-Clark Corporation, "Kimberly-Clark Reports Strong Finish to Second Year of Transformation," January 27, 2026. https://www.prnewswire.com/news-releases/kimberly-clark-reports-strong-finish-to-second-year-of-transformation-302670526.html

[18] Business Journal Daily, "Kimberly-Clark Reports Q4, 2025 Results," January 27, 2026. https://businessjournaldaily.com/kimberly-clark-reports-q4-2025-results/

[19] Kimberly-Clark Corporation, Form 10-K for the fiscal year ended December 31, 2025, filed February 12, 2026 (approximately 36,000 employees as of December 31, 2025; principal executive office in the Dallas, Texas metropolitan area). https://www.sec.gov/Archives/edgar/data/55785/000162828026007567/kmb-20251231.htm